Kevin McGrath
Keine laufenden Positionen mehr
Profil
Kevin McGrath is Senior Director of Finance and Administration for Guava Technologies, Inc. He joined Guava Technologies, Inc. in 2000.
He was Director of Finance for the North American Operations of GN ReSound Corporation.
He received an MBA from the University of New Hampshire and a Bachelor's degree from Boston College.
Ehemalige bekannte Positionen von Kevin McGrath
| Unternehmen | Position | Ende |
|---|---|---|
| Dupont Capital, Inc. | Corporate Officer/Principal | - |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| SIEMENS AG | Corporate Officer/Principal | - |
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Finanzdirektor/CFO | - |
Ausbildung von Kevin McGrath
| University of New Hampshire | Masters Business Admin |
| Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIEMENS AG | Producer Manufacturing |
| Private Unternehmen | 3 |
|---|---|
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Commercial Services |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Health Technology |
| Dupont Capital, Inc. | Finance |